000			03285nam a22003255i 4500
999			_c399092 _d399092
001			399092
003			ES-MaUEC
005			20240322090723.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			230309s2023 si | o |||| 0|eng d
020			_a9789811900273
024	7		_a10.1007/978-981-19-0027-3 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC660.A2 _b2023 EB
245	0	0	_aAdvances in Diabetes Research and Management _cedited by Rana Noor
250			_a1st ed. 2023.
264		1	_aSingapore _bSpringer Nature Singapore _c2023
300			_a1 recurso en línea
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_a1. Biochemical Assay for Measuring Diabetes Mellitus -- 2. Diabetes and other comorbidities-Microvascular and Macrovascular diseases Diabetes and Cancer -- 3. Diabetes and Cardiovascular Disorder -- 4. Diabetes and Neurological Disorders -- 5. Diabetic and nephropathy -- 6. Technology in the management of type 1 and type 2 diabetes mellitus - recent status and future prospects -- 7. The Broader aspects of Treating Diabetes with the Application of Nanobiotechnology -- 8. A comprehensive pharmacological appraisal of Indian traditional medicinal plants with Antidiabetic potential -- 9. Diabetes management - From "Painful" pricks to "Painfree" bliss -- 10. Diabetes mellitus and iPSC based therapy -- 11. ketogenic diet and. Diabetics' of gut microbe on diabetics.
520			_aThis book discusses the latest research in the pathophysiology, diagnosis, and screening of diabetes and its management. It reviews novel technologies for early diagnosis and highlights the molecular mechanisms of microvascular and macrovascular complications of diabetes 2 mellitus. The book covers the applications of nanotechnology in diagnostics, monitoring, and treatment of diabetes mellitus. The chapter also presents the latest developments in differentiating pancreatic cells from PSCs and illustrates the challenges of their therapeutic application in treating diabetes. The book also explores the prospective medicinal plants comprising either plant extract or isolated bioactive phytoconstituents bearing anti-diabetic potential, which has been reported in several in vitro, in vivo, or clinical studies. It further examines the major mechanisms involved in cardiovascular complications among type 2 diabetes mellitus individuals and discusses the various pharmacological interventions and agents developed to delay cardiovascular events and thereby the quality and duration of the patients. Towards the end, the book summarizes the potential impact of ketogenic diets on diabetic patients, and the role of genetic vulnerability in diabetic nephropathy. As such, this book is a valuable source for students, researchers, and practitioners working in glucose metabolism, diabetes, and human health.
988			_aSpringer_BiomedLife_2023
650		7	_2embne _9138582 _aDiabetes
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-19-0027-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b03/2024 _dz _ek _zSI